{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:40:31Z","timestamp":1790196031355,"version":"4.1.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,12]],"date-time":"2021-09-12T00:00:00Z","timestamp":1631404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,12]],"date-time":"2021-09-12T00:00:00Z","timestamp":1631404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>A first-year interim analysis of this two-year study suggested that intra-articular injections of highly purified, natural-origin polynucleotides and hyaluronic acid (HA) as a fixed combination (PNHA) might improve knee function and joint pain more effectively than HA alone in patients with knee osteoarthritis (OA). The purpose of the second-year analysis herein described was to verify whether the first-year interim outcomes persist over the whole two-year period.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Randomised, double-blind, HA-controlled clinical trial in 100 knee OA patients (98 randomised, 79 completing the study) in a high-specialisation tertiary care setting. The hypothesised difference of efficacy between PNHA and HA for the original sample size estimate is 20%. Treatment cycle: three\u00a0intra-articular knee injections of either PNHA or HA,\u00a0at baseline and weekly for two weeks. Evaluations: Western Ontario and McMaster Universities (WOMAC) score and Knee Society Score (KSS) as, respectively, primary and secondary endpoints, evaluated at baseline and after 2, 6, 12, and 24\u2009months; synovial fluid levels of mediators (at baseline and the end of the treatment cycle). Adverse effects investigated at each control visit. Statistical analysis: Kruskal-Wallis test for independent samples (nonparametric one-way analysis of variance) after correction of means for age, Body Mass Index and Kellgren-Lawrence grade. If significant, pairwise post-hoc Sidak multiple comparisons.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>KSS total score and KSS pain item: significant improvement in both groups, with significantly more pain improvement in patients treated with PNHA (2-point reduction) than HA (1-point reduction). Both groups experienced significant long-term reductions in WOMAC total scores: significantly stronger in PNHA-treated patients after 24\u2009months with a steady difference of 16% favouring PNHA in WOMAC pain subscore. No clinically significant adverse events in either group.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The outcomes of the 2-year study confirmed that a short cycle of intra-articular treatment (3 weekly double-blind injections) with polynucleotides (long-acting viscosupplementation properties, chondrocyte activation, pain-relieving properties) in fixed combination with high molecular weight hyaluronic acid is more effective in improving knee function and pain in knee OA patients than HA alone. PNHA may be elective for viscosupplementation in knee OA patients with fastidious and resistant pain\u00a0and worsening disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration<\/jats:title><jats:p><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02417610?term=NCT02417610&amp;cntry=IT&amp;draw=2&amp;rank=1\">NCT02417610<\/jats:ext-link>.<\/jats:p><jats:p>Registration, 15\/04\/2015.<\/jats:p><jats:p><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/clinicaltrials.gov\">ClinicalTrials.gov<\/jats:ext-link>database link:<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12891-021-04648-0","type":"journal-article","created":{"date-parts":[[2021,9,12]],"date-time":"2021-09-12T14:04:01Z","timestamp":1631455441000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Randomised, double-blind comparison of a fixed co-formulation of intra-articular polynucleotides and hyaluronic acid versus hyaluronic acid alone in the treatment of knee osteoarthritis: two-year follow-up"],"prefix":"10.1186","volume":"22","author":[{"given":"Cesare","family":"Stagni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Rocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Mazzotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolandrea","family":"Del Piccolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Rani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Govoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Vivarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Veronesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena","family":"Fini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dante","family":"Dallari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,12]]},"reference":[{"issue":"3","key":"4648_CR1","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.joca.2014.01.003","volume":"22","author":"TE McAlindon","year":"2014","unstructured":"McAlindon TE, Bannuru RR, Sullivan MC, Arden NK, Berenbaum F, Bierma-Zeinstra SM, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthr Cartil. 2014;22(3):363\u201388. https:\/\/doi.org\/10.1016\/j.joca.2014.01.003.","journal-title":"Osteoarthr Cartil"},{"issue":"2","key":"4648_CR2","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.semarthrit.2015.04.011","volume":"45","author":"Y Henrotin","year":"2015","unstructured":"Henrotin Y, Raman R, Richette P, Bard H, Jerosch J, Conrozier T, et al. Consensus statement on viscosupplementation with hyaluronic acid for the management of osteoarthritis. Semin Arthritis Rheum. 2015;45(2):140\u20139. https:\/\/doi.org\/10.1016\/j.semarthrit.2015.04.011.","journal-title":"Semin Arthritis Rheum"},{"issue":"11","key":"4648_CR3","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.joca.2019.06.011","volume":"27","author":"RR Bannuru","year":"2019","unstructured":"Bannuru RR, Osani MC, Vaysbrot EE, Arden NK, Bennell K, Bierma-Zeinstra SMA, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthr Cartil. 2019;27(11):1578\u201389. https:\/\/doi.org\/10.1016\/j.joca.2019.06.011.","journal-title":"Osteoarthr Cartil"},{"issue":"7","key":"4648_CR4","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00167-009-1039-y","volume":"18","author":"R Vanelli","year":"2010","unstructured":"Vanelli R, Costa P, Rossi SMP, Benazzo F. Efficacy of intra-articular polynucleotides in the treatment of knee osteoarthritis: a randomised, double-blind clinical trial. Knee Surg Sports Traumatol Arthrosc. 2010;18(7):901\u20137. https:\/\/doi.org\/10.1007\/s00167-009-1039-y.","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"issue":"2","key":"4648_CR5","first-page":"543","volume":"27","author":"R Saggini","year":"2013","unstructured":"Saggini R, Di Stefano A, Cavezza T, Saladino G, Bellomo RG. Intrarticular treatment of osteoarthropathy knee with polynucleotides: a pilot study with medium-term follow-up. J Biol Regul Homeost Agents. 2013;27(2):543\u20139.","journal-title":"J Biol Regul Homeost Agents"},{"issue":"3","key":"4648_CR6","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.knee.2014.02.010","volume":"21","author":"LS Giarratana","year":"2014","unstructured":"Giarratana LS, Marelli BM, Crapanzano C, De Martinis SE, Gala L, Ferraro M, et al. A randomized, double-blind clinical trial on the treatment of knee osteoarthritis: the efficacy of polynucleotides compared to standard hyaluronan viscosupplementation. Knee. 2014;21(3):661\u20138. https:\/\/doi.org\/10.1016\/j.knee.2014.02.010.","journal-title":"Knee."},{"key":"4648_CR7","first-page":"124","volume":"3","author":"S Guizzardi","year":"2013","unstructured":"Guizzardi S, Uggeri J, Belletti S, Cattarini G. Hyaluronate increases polynucleotides effect on human cultured fibroblasts. J Cosmet Dermatol Sci Appl. 2013;3:124\u20138.","journal-title":"J Cosmet Dermatol Sci Appl"},{"issue":"1","key":"4648_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/JSM.0000000000000569","volume":"30","author":"D Dallari","year":"2020","unstructured":"Dallari D, Sabbioni G, Del Piccolo N, Carubbi C, Veronesi F, Torricelli P, et al. Efficacy of intra-articular polynucleotides associated with hyaluronic acid versus hyaluronic acid alone in the treatment of knee osteoarthritis: a randomised, double-blind, controlled clinical trial. Clin J Sport Med. 2020;30(1):1\u20137. https:\/\/doi.org\/10.1097\/JSM.0000000000000569.","journal-title":"Clin J Sport Med"},{"issue":"8","key":"4648_CR9","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1007\/s11999-016-4732-4","volume":"474","author":"MD Kohn","year":"2016","unstructured":"Kohn MD, Sassoon AA, Fernando ND. Classifications in brief: Kellgren-Lawrence classification of osteoarthritis. Clin Orthop Relat Res. 2016;474(8):1886\u201393. https:\/\/doi.org\/10.1007\/s11999-016-4732-4.","journal-title":"Clin Orthop Relat Res"},{"key":"4648_CR10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00003086-198911000-00004","volume":"248","author":"JN Insall","year":"1989","unstructured":"Insall JN, Dorr LD, Scott RD, Scott WN. Rationale of the knee society clinical rating system. Clin Orthop Relat Res. 1989;248:13\u20134.","journal-title":"Clin Orthop Relat Res"},{"issue":"12","key":"4648_CR11","first-page":"1833","volume":"15","author":"N Bellamy","year":"1988","unstructured":"Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988;15(12):1833\u201340.","journal-title":"J Rheumatol"},{"issue":"3","key":"4648_CR12","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/cbf.2875","volume":"31","author":"L Gennero","year":"2013","unstructured":"Gennero L, Denysenko T, Calisti GF, Vercelli A, Vercelli CM, Amedeo S, et al. Protective effects of polydeoxyribonucleotides on cartilage degradation in experimental cultures. Cell Biochem Funct. 2013;31(3):214\u201327. https:\/\/doi.org\/10.1002\/cbf.2875.","journal-title":"Cell Biochem Funct"},{"issue":"7","key":"4648_CR13","doi-asserted-by":"publisher","first-page":"7081","DOI":"10.1016\/j.actbio.2013.03.005","volume":"9","author":"A Fakhari","year":"2013","unstructured":"Fakhari A, Berkland C. Applications and merging trends of hyaluronic acid tissue engineering, as a dermal filler and in osteoarthritis treatment. Acta Biomater. 2013;9(7):7081\u201392. https:\/\/doi.org\/10.1016\/j.actbio.2013.03.005.","journal-title":"Acta Biomater"},{"issue":"11","key":"4648_CR14","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1002\/art.30538","volume":"63","author":"A Bitto","year":"2011","unstructured":"Bitto A, Polito F, Irrera N, D\u2019Ascola A, Avenoso A, Nastasi G, et al. Polydeoxyribonucleotide reduces cytokine production and the severity of collagen-induced arthritis by stimulation of adenosine a(2A) receptor. Arthritis Rheum. 2011;63(11):3364\u201371. https:\/\/doi.org\/10.1002\/art.30538.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"4648_CR15","doi-asserted-by":"publisher","first-page":"181","DOI":"10.5999\/aps.2013.40.3.181","volume":"40","author":"KI Chung","year":"2013","unstructured":"Chung KI, Kim HK, Kim WS, Bae TH. The effects of polydeoxyribonucleotides on the survival of random pattern skin flaps in rats. Arch Plast Surg. 2013;40(3):181\u20136. https:\/\/doi.org\/10.5999\/aps.2013.40.3.181.","journal-title":"Arch Plast Surg"},{"issue":"11","key":"4648_CR16","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1016\/j.joca.2015.02.009","volume":"23","author":"HN Daghestani","year":"2015","unstructured":"Daghestani HN, Kraus VB. Inflammatory biomarkers in osteoarthritis. Osteoarthr Cartil. 2015;23(11):1890\u20136. https:\/\/doi.org\/10.1016\/j.joca.2015.02.009.","journal-title":"Osteoarthr Cartil"},{"key":"4648_CR17","first-page":"153","volume":"7","author":"B Heidari","year":"2016","unstructured":"Heidari B, Hajian-Tilaki K, Babaei M. Determinants of pain in patients with symptomatic knee osteoarthritis. Caspian J Intern Med. 2016;7:153\u201361.","journal-title":"Caspian J Intern Med"},{"key":"4648_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nut.2016.08.004","volume":"33","author":"N Akhtar","year":"2017","unstructured":"Akhtar N, Khan NM, Ashruf OS, Haqqi TM. Inhibition of cartilage degradation and suppression of PGE2 and MMPs expression by pomegranate fruit extract in a model of posttraumatic osteoarthritis. Nutrition. 2017;33:1\u201313. https:\/\/doi.org\/10.1016\/j.nut.2016.08.004.","journal-title":"Nutrition."}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-021-04648-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12891-021-04648-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-021-04648-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T00:54:27Z","timestamp":1673225667000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-021-04648-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,12]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["4648"],"URL":"https:\/\/doi.org\/10.1186\/s12891-021-04648-0","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,12]]},"assertion":[{"value":"18 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Review Board of the Rizzoli Orthopedic Institute reviewed all study materials such as study protocol, informed consent forms, electronic clinical report form, CVs of authors, Etc. for ethical problems. All relevant documents (IRB approval certificate and approved study materials) are available from Dr. Dante Dallari or the corresponding author, Martina Rocchi, MD, on request. The principles of the Declaration of Helsinki were always respected. The study was registered in thedatabase of privately and publicly funded clinical studies conducted worldwide (Identifier: NCT02417610).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The manuscript contains no individual patient\u2019s data in any form\u2014all authors consent to the manuscript\u2019s publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing or conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"773"}}